Niam Yadlapati, an eight year old cancer survivor and Sage Canyon School third grader, recently hosted the very successful ...

Vincerx Pharma announces early results for VIP943 and VIP236 in Phase 1 studies targeting hard-to-treat cancers, with ...

Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology, today announced that it ...

UI Health Care and Mission Cancer + Blood announce an agreement to create a $280M statewide cancer care network to tackle ...

Leukaemia & Lymphoma NI (LLNI) marked its 60th anniversary in style with a Black Tie and Diamonds Gala Ball, celebrating six ...

For patients with relapsed/refractory large B-cell lymphoma (LBCL), the autologous, CD19-directed, 4-1BB chimeric antigen ...

Chair of Tampa Light the Night, Laura Sherman, joins Gayle Guyardo, the host of the global health and wellness show, Bloom, ...

Patients with a rare blood cancer that has relapsed or become resistant to treatment have shown a high response rate to a ...

David Reitz has supported the Leukemia & Lymphoma Society with Light the Night walks raising over $46,000. This year he is ...

The FDA granted a priority review to acalabrutinib for the treatment of previously untreated adults with mantle cell lymphoma ...

Many people were lighting the sky in Yeatman's Cove Thursday night. They're bringing hope to patients and families impacted by blood cancer.

Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...